Related Experiment Videos
Solid-phase synthesis of thalidomide and its analogues
Zili Xiao1, Kevin Schaefer, Steven Firestine
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, Ohio 43210, USA.
Journal of Combinatorial Chemistry
|March 12, 2002
Summary
A new solid-phase synthesis method efficiently produces thalidomide and its analogues. This approach yields high-purity compounds, offering a valuable tool for drug discovery and development.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Synthetic Chemistry
Background:
- Thalidomide and its analogues are important therapeutic agents.
- Developing efficient and scalable synthesis methods is crucial for their study and application.
- Existing synthesis methods may have limitations in yield, purity, or scalability.
Purpose of the Study:
- To develop a novel solid-phase synthesis strategy for thalidomide and its analogues.
- To create a versatile method for producing a diverse range of thalidomide analogues.
- To achieve high yields and purities in the synthesized compounds.
Main Methods:
- Utilized a solid-phase synthesis approach.
- Coupled hydroxymethyl polystyrene with phthalic anhydride to form a resin-linked acid.
- Reacted the resin-linked acid with primary amines, followed by acid or base treatment to yield thalidomide analogues.
Main Results:
- Successfully synthesized thalidomide and various analogues using the novel solid-phase method.
- Achieved high yields for most analogues, ranging from 40.3% to 98.1% over three steps.
- Obtained high purities for the synthesized compounds, between 92.3% and 98.9%.
Conclusions:
- The developed solid-phase synthesis is an effective and efficient method for producing thalidomide and its analogues.
- This strategy allows for the creation of diverse analogues with controlled phthalimide ring structures.
- The high yields and purities demonstrate the potential of this method for drug discovery and development.